FRESENIUS MEDICAL CARE-ADR (FMS) Stock Fundamental Analysis

NYSE:FMS • US3580291066

23.37 USD
-0.1 (-0.43%)
At close: Mar 3, 2026
23.37 USD
0 (0%)
After Hours: 3/3/2026, 7:13:52 PM
Fundamental Rating

5

Overall FMS gets a fundamental rating of 5 out of 10. We evaluated FMS against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of FMS while its profitability can be described as average. FMS is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • FMS had positive earnings in the past year.
  • FMS had a positive operating cash flow in the past year.
  • Each year in the past 5 years FMS has been profitable.
  • FMS had a positive operating cash flow in each of the past 5 years.
FMS Yearly Net Income VS EBIT VS OCF VS FCFFMS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

1.2 Ratios

  • FMS's Return On Assets of 3.16% is fine compared to the rest of the industry. FMS outperforms 65.35% of its industry peers.
  • The Return On Equity of FMS (7.35%) is better than 65.35% of its industry peers.
  • FMS has a Return On Invested Capital of 5.30%. This is comparable to the rest of the industry: FMS outperforms 57.43% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for FMS is significantly below the industry average of 9.13%.
  • The last Return On Invested Capital (5.30%) for FMS is above the 3 year average (4.02%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROIC 5.3%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
FMS Yearly ROA, ROE, ROICFMS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • FMS has a better Profit Margin (4.98%) than 79.21% of its industry peers.
  • FMS's Profit Margin has declined in the last couple of years.
  • With a decent Operating Margin value of 9.00%, FMS is doing good in the industry, outperforming 77.23% of the companies in the same industry.
  • In the last couple of years the Operating Margin of FMS has declined.
  • FMS's Gross Margin of 25.62% is in line compared to the rest of the industry. FMS outperforms 52.48% of its industry peers.
  • FMS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 9%
PM (TTM) 4.98%
GM 25.62%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
FMS Yearly Profit, Operating, Gross MarginsFMS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), FMS is creating some value.
  • Compared to 1 year ago, FMS has less shares outstanding
  • The number of shares outstanding for FMS has been reduced compared to 5 years ago.
  • Compared to 1 year ago, FMS has a worse debt to assets ratio.
FMS Yearly Shares OutstandingFMS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
FMS Yearly Total Debt VS Total AssetsFMS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • FMS has an Altman-Z score of 1.84. This is not the best score and indicates that FMS is in the grey zone with still only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 1.84, FMS perfoms like the industry average, outperforming 45.54% of the companies in the same industry.
  • The Debt to FCF ratio of FMS is 6.19, which is on the high side as it means it would take FMS, 6.19 years of fcf income to pay off all of its debts.
  • FMS has a Debt to FCF ratio (6.19) which is in line with its industry peers.
  • FMS has a Debt/Equity ratio of 0.65. This is a neutral value indicating FMS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of FMS (0.65) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Altman-Z 1.84
ROIC/WACC1.01
WACC5.24%
FMS Yearly LT Debt VS Equity VS FCFFMS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that FMS should not have too much problems paying its short term obligations.
  • FMS has a Current ratio of 1.26. This is comparable to the rest of the industry: FMS outperforms 49.51% of its industry peers.
  • A Quick Ratio of 0.92 indicates that FMS may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.92, FMS is doing worse than 68.32% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.92
FMS Yearly Current Assets VS Current LiabilitesFMS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 32.00% over the past year.
  • Measured over the past years, FMS shows a decrease in Earnings Per Share. The EPS has been decreasing by -1.51% on average per year.
  • The Revenue has been growing slightly by 1.51% in the past year.
  • The Revenue has been growing slightly by 1.91% on average over the past years.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%

3.2 Future

  • FMS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.03% yearly.
  • The Revenue is expected to grow by 3.69% on average over the next years.
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
FMS Yearly Revenue VS EstimatesFMS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 5B 10B 15B 20B 25B
FMS Yearly EPS VS EstimatesFMS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 9.58, the valuation of FMS can be described as reasonable.
  • 94.06% of the companies in the same industry are more expensive than FMS, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of FMS to the average of the S&P500 Index (26.83), we can say FMS is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 10.23, the valuation of FMS can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of FMS indicates a rather cheap valuation: FMS is cheaper than 90.10% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.95, FMS is valued rather cheaply.
Industry RankSector Rank
PE 9.58
Fwd PE 10.23
FMS Price Earnings VS Forward Price EarningsFMS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • FMS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. FMS is cheaper than 89.11% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, FMS is valued cheaply inside the industry as 90.10% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.72
EV/EBITDA 6.14
FMS Per share dataFMS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.07%
EPS Next 3Y6.69%

6

5. Dividend

5.1 Amount

  • FMS has a Yearly Dividend Yield of 3.61%.
  • FMS's Dividend Yield is rather good when compared to the industry average which is at 0.48. FMS pays more dividend than 98.02% of the companies in the same industry.
  • FMS's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.61%

5.2 History

  • The dividend of FMS has a limited annual growth rate of 4.43%.
  • FMS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • FMS has decreased its dividend in the last 3 years.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years2
FMS Yearly Dividends per shareFMS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

  • FMS pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • The dividend of FMS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
FMS Yearly Income VS Free CF VS DividendFMS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B
FMS Dividend Payout.FMS Dividend Payout, showing the Payout Ratio.FMS Dividend Payout.PayoutRetained Earnings

FRESENIUS MEDICAL CARE-ADR

NYSE:FMS (3/3/2026, 7:13:52 PM)

After market: 23.37 0 (0%)

23.37

-0.1 (-0.43%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24
Earnings (Next)05-05
Inst Owners43.91%
Inst Owner Change6.19%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.71B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target27.2 (16.39%)
Short Float %0.45%
Short Ratio3.12
Dividend
Industry RankSector Rank
Dividend Yield 3.61%
Yearly Dividend0.84
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-2.48%
PT rev (3m)-2.87%
EPS NQ rev (1m)12.25%
EPS NQ rev (3m)14.55%
EPS NY rev (1m)0%
EPS NY rev (3m)2.83%
Revenue NQ rev (1m)0.31%
Revenue NQ rev (3m)0.62%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.39%
Valuation
Industry RankSector Rank
PE 9.58
Fwd PE 10.23
P/S 0.6
P/FCF 6.72
P/OCF 4.37
P/B 0.88
P/tB N/A
EV/EBITDA 6.14
EPS(TTM)2.44
EY10.44%
EPS(NY)2.28
Fwd EY9.78%
FCF(TTM)3.48
FCFY14.87%
OCF(TTM)5.34
OCFY22.87%
SpS39.13
BVpS26.53
TBVpS-3.02
PEG (NY)N/A
PEG (5Y)N/A
Graham Number38.17
Profitability
Industry RankSector Rank
ROA 3.16%
ROE 7.35%
ROCE 7.13%
ROIC 5.3%
ROICexc 5.78%
ROICexgc 16.63%
OM 9%
PM (TTM) 4.98%
GM 25.62%
FCFM 8.88%
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 6.19
Debt/EBITDA 2.64
Cap/Depr 62.47%
Cap/Sales 4.78%
Interest Coverage 4.9
Cash Conversion 82.09%
Profit Quality 178.22%
Current Ratio 1.26
Quick Ratio 0.92
Altman-Z 1.84
F-Score8
WACC5.24%
ROIC/WACC1.01
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-6.53%
EPS Next 2Y2.07%
EPS Next 3Y6.69%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year0.74%
Revenue Next 2Y2.42%
Revenue Next 3Y2.64%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year76.05%
EBIT Next 3Y25.14%
EBIT Next 5Y15.34%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%

FRESENIUS MEDICAL CARE-ADR / FMS FAQ

What is the fundamental rating for FMS stock?

ChartMill assigns a fundamental rating of 5 / 10 to FMS.


Can you provide the valuation status for FRESENIUS MEDICAL CARE-ADR?

ChartMill assigns a valuation rating of 7 / 10 to FRESENIUS MEDICAL CARE-ADR (FMS). This can be considered as Undervalued.


What is the profitability of FMS stock?

FRESENIUS MEDICAL CARE-ADR (FMS) has a profitability rating of 5 / 10.


What is the expected EPS growth for FRESENIUS MEDICAL CARE-ADR (FMS) stock?

The Earnings per Share (EPS) of FRESENIUS MEDICAL CARE-ADR (FMS) is expected to decline by -6.53% in the next year.


Is the dividend of FRESENIUS MEDICAL CARE-ADR sustainable?

The dividend rating of FRESENIUS MEDICAL CARE-ADR (FMS) is 6 / 10 and the dividend payout ratio is 43.19%.